Search clinical trials for: Buprenorphine/naloxone

Total 698 results

University of California, San Diego
Society of Family Planning

Completed

Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion (ABCD&E)

Procedural Pain | Buprenorphine | Dilation and Evacuation | Analgesics | Adjuvants, Anesthesia

United States
Brigham and Women's Hospital
University of Utah

Not yet recruiting

Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder

Opioid Use Disorder
University Hospital, Clermont-Ferrand

Active, not recruiting

High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid (SEVROP)

High Dosage Buprenorphine

France
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Opioid Addicts - 1

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care

Substance Abuse, Intravenous | Opioid-Related Disorders | Heroin Dependence

United States
Mundipharma Research Limited

Terminated

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain (BUP1501)

Chemotherapy Induced Mucositis | Mouth Pain

Denmark, United Kingdom
Chong Kun Dang Pharmaceutical

Completed

CKD-337 Drug Interaction Study

Dyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)

Korea, Republic of
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Protocol - 1

Opioid-Related Disorders

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Clinical Trial of Buprenorphine - 3

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
Grünenthal GmbH

Terminated

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

Healthy

Germany
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Healthy

Germany
Danish University of Pharmaceutical Sciences

Unknown

Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers

Healthy Volunteers

Denmark
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use (ROLDI)

Opioid Use Disorder
Seoul National University Hospital

Recruiting

Neuroimaging Study on the Effect of Transdermal Buprenorphine in Complex Regional Pain Syndrome Patients

Complex Regional Pain Syndromes

Korea, Republic of
Peter Rossing

Completed

Microalbuminuria and Allopurinol in Type 1 Diabetes (MIKAL)

Type 1 Diabetes | Diabetic Nephropathy

Denmark
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Heroin Dependence | Cocaine-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Columbia University

Completed

IV Cocaine Abuse: A Laboratory Model - 3

Cocaine-Related Disorders

United States
Tehran University of Medical Sciences

Completed

Buprenorphine in Acute Renal Colic Pain Management

Renal Colic | Acute Pain Management

Iran, Islamic Republic of
Norpharma A/S
Mundipharma Finland

Completed

Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine

Pain | Osteoarthritis

Finland
Johns Hopkins Bloomberg School of Public Health
Centers for Disease Control and Prevention

Completed

An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses

Overdose

United States
National Institute on Drug Abuse (NIDA)

Completed

Tramadol to Reduce Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

Opioid-Related Disorders | Heroin Dependence

United States
Georgetown University
National Institute on Drug Abuse (NIDA)

Terminated

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Pain | Buprenorphine

United States
INSYS Therapeutics Inc

Completed

Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Pain

United States
University of Alabama at Birmingham
National Institute on Drug Abuse (NIDA)

Completed

Relapse Prevention to Reduce HIV Among Women Prisoners

HIV | Opioid Dependence
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Unknown

Mechanisms of Hypoglycemia Associated Autonomic Failure

Diabetes Mellitus | Hypoglycemia | Autonomic Failure

United States
Virginia Commonwealth University
Indivior, PLC.

Withdrawn

Virginia Opioid Treatment-Emergency Department (VOT-ED)

Opioid Use Disorder
Braeburn Pharmaceuticals

Completed

Phase II Pharmacokinetics Study of CAM2038

Chronic Pain | Opioid Use Disorder

United States
Ain Shams University

Completed

Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Endoscopic Retrograde Cholangiopancreatography
Shalvata Mental Health Center

Unknown

Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients

Depression

Israel
University of British Columbia

Completed

Naloxone for the Treatment of Opioid-Induced Pruritus

Pruritus

Canada
Brian Williams
University of Pittsburgh

Completed

4-drug Nerve Block Versus Plain Local Anesthetic for Knee and Hip Arthroplasty Analgesia in Veterans

Pain

United States
Centre Hospitalier Universitaire de Nīmes

Recruiting

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode (BUPRIS)

Suicidal Ideation | Major Depressive Episode

France
Thomas Jefferson University
Chiesi Farmaceutici S.p.A.

Completed

Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (B-PHORE)

Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1

Substance-Related Disorders | Opioid-Related Disorders | Cocaine-Related Disorders

United States
University of Dundee
British Heart Foundation; NHS Tayside

Completed

Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease (APOSA-PAD)

Peripheral Arterial Disease

United Kingdom
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Opioid-Related Disorders | Cocaine-Related Disorders

United States
Washington University School of Medicine
Reckitt Benckiser LLC

Completed

Buprenorphine Used With Treatment Resistant Depression in Older Adults (IRLGreyB)

Depression | Major Depressive Disorder

United States
Centre for Addiction and Mental Health
Reckitt Benckiser LLC

Completed

Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine ((IRLGREY-B))

Depression | Major Depressive Disorder

Canada
Montefiore Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Onsite Buprenorphine Treatment at Syringe Exchange Programs (O-BMT)

Opiate Addiction

United States

Search clinical trials for: Buprenorphine/naloxone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations